| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |